Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Review of Covid-19 Vaccines and Major Considerations for Diabetic Patients Publisher Pubmed



Soltani S1, 2 ; Zandi M1, 2 ; Shiri Aghbash P3 ; Rezaei M4 ; Mohammadzadeh N5 ; Afsharifar A6 ; Poortahmasebi V3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Bacteriology and Virology, Tabriz University of Medical Sciences, Tabriz, Iran
  4. 4. Department of Plant Protection, Shiraz University, Shiraz, Iran
  5. 5. Health Reference Laboratory, Tabriz University of Medical Sciences, Tabriz, Iran
  6. 6. Department of Plant Protection, University of Shiraz, Shiraz, Iran

Source: Biotechnology and Applied Biochemistry Published:2022


Abstract

The necessity and impact of SARS-CoV2 on the world's health have led to developing and producing practical and useful vaccines for this deadly respiratory virus. Since April 2020, a vaccine for the virus has been developed. Given that comorbidities such as diabetes, hypertension, and cardiovascular disease are more prone to viruses and the risk of infection, vaccines should be designed to protect against high-risk respiratory illnesses. Including SARS, MERS, influenza, and the SARS-CoV-2 provide a safe immune response. Here, we review the information and studies that have been done to help develop strategies and perspectives for producing a safe and ideal vaccine to prevent COVID-19 in normal people, especially at high-risk groups such as diabetes patients. © 2020 International Union of Biochemistry and Molecular Biology, Inc.
Other Related Docs
9. Immune Profiling of Sars-Cov-2; What We Know and What We Don’T Know, Iranian Journal of Allergy# Asthma and Immunology (2023)
13. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
18. Insights Into the Sars-Cov2 Outbreak; the Great Global Challenge: A Mini Review, Journal of Cellular and Molecular Anesthesia (2020)
20. Potential Antiviral Immune Response Against Covid-19: Lessons Learned From Sars-Cov, Advances in Experimental Medicine and Biology (2021)
28. Host Factors: Implications in Immunopathogenesis of Covid-19, Pathology Research and Practice (2021)
42. Design of a Multi-Epitope Vaccine Against Sars-Cov-2 Using Immunoinformatics Approach, International Journal of Biological Macromolecules (2020)
49. Covid-19: Significance of Antibodies, Human Antibodies (2020)